Stocktoria

PMGC Holdings Inc. ELAB

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2023-11-21

PMGC Holdings Inc. statistics & valuation

Market cap$5.2M
P / S8.8×
P / B0.7×
Net margin-1313.0%
Return on equity-98.9%
FCF margin-1080.5%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-234.90% -251.20% -1313.00% 2022202320242025
Gross margin (%)
58.40% 66.20% 31.40% 2022202320242025
Operating margin (%)
2022202320242025
Return on equity (%)
-159.10% -112.40% -93.80% -98.90% 2022202320242025
Shares outstanding
9.6M 12384 5226 80699 2022202320242025
Net debt ($)
2022202320242025
Share buybacks ($)
2022202320242025
Return on assets (%)
-95.10% -82.90% -69.40% -60.20% 2022202320242025
Free cash flow margin (%)
-266.70% -1080.50% 2022202320242025
Debt / equity (×)
2022202320242025
EPS ($)
-$0.19 -$0.40 2022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022
Gross margin31.4%—66.2%58.4%
Net margin-1313.0%—-251.2%-234.9%
FCF margin-1080.5%—-266.7%—
Return on assets-60.2%-69.4%-82.9%-95.1%
Return on equity-98.9%-93.8%-112.4%-159.1%
Current ratio1.743.363.792.64

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.